Olmesartan Medox/hctz 40-25mg Tab

Manufacturer AUROBINDO Active Ingredient Olmesartan and Hydrochlorothiazide(ole me SAR tan & hye droe klor oh THYE a zide) Pronunciation OLE-me-SAR-tan med-OX-oh-mil & HYE-droe-KLOR-oh-THYE-a-zide
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.
đŸˇī¸
Drug Class
Antihypertensive
đŸ§Ŧ
Pharmacologic Class
Angiotensin II Receptor Blocker (ARB) and Thiazide Diuretic Combination
🤰
Pregnancy Category
Category D
✅
FDA Approved
Mar 2003
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is a combination of two drugs used to treat high blood pressure (hypertension). Olmesartan is an 'ARB' that helps relax blood vessels, and hydrochlorothiazide is a 'water pill' (diuretic) that helps your body get rid of extra salt and water. Together, they help lower your blood pressure.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food. Continue taking the medication as directed by your doctor or healthcare provider, even if you start to feel well.

It's essential to establish a routine when taking this medication. Try to take it at the same time every day to help you remember. Since this medication may increase your urine production, it's best to avoid taking it too close to bedtime to minimize sleep disruptions.

Staying Hydrated

Drink plenty of non-caffeinated liquids throughout the day, unless your doctor advises you to limit your fluid intake.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from the bathroom. Keep all medications in a safe and secure location, out of the reach of children and pets. When your medication is no longer needed or has expired, dispose of it properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your doctor or pharmacist. If you have questions about disposing of your medication, consult with your pharmacist, who may be aware of drug take-back programs in your area.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Continue to follow a low-sodium diet as recommended by your doctor.
  • Engage in regular physical activity as advised.
  • Limit alcohol intake.
  • Maintain a healthy weight.
  • Do not use potassium supplements or salt substitutes containing potassium without consulting your doctor.
  • Avoid sudden changes in position (e.g., standing up quickly) to prevent dizziness.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: One 40 mg/25 mg tablet orally once daily

Condition-Specific Dosing:

initialTherapy: Not recommended for initial therapy. Should be used after titration with individual components.
maximumDose: Olmesartan 40 mg/Hydrochlorothiazide 25 mg once daily
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dose adjustment for CrCl > 30 mL/min.
Moderate: Not recommended for patients with moderate renal impairment (CrCl < 30 mL/min) due to the hydrochlorothiazide component.
Severe: Contraindicated in patients with anuria or severe renal impairment (CrCl < 30 mL/min).
Dialysis: Not recommended for patients on dialysis.

Hepatic Impairment:

Mild: No dose adjustment for olmesartan. Use with caution for hydrochlorothiazide.
Moderate: No dose adjustment for olmesartan. Use with caution for hydrochlorothiazide.
Severe: Use with caution, as minor alterations of fluid and electrolyte balance may precipitate hepatic coma due to the hydrochlorothiazide component. Olmesartan not studied in severe hepatic impairment.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Olmesartan medoxomil is a prodrug that is rapidly converted to olmesartan, an angiotensin II receptor blocker (ARB). Olmesartan selectively blocks the binding of angiotensin II to the AT1 receptor in many tissues, including vascular smooth muscle and the adrenal gland. This inhibits the vasoconstrictor and aldosterone-secreting effects of angiotensin II, leading to vasodilation, reduced aldosterone secretion, and decreased sodium and water reabsorption. Hydrochlorothiazide is a thiazide diuretic that inhibits the reabsorption of sodium and chloride ions in the distal convoluted tubule, leading to increased excretion of sodium, chloride, and water. It also increases potassium and magnesium excretion and decreases calcium excretion.
📊

Pharmacokinetics

Absorption:

Bioavailability: Olmesartan: ~26%; Hydrochlorothiazide: 65-75%
Tmax: Olmesartan: 1-2 hours; Hydrochlorothiazide: 1-2.5 hours
FoodEffect: Olmesartan: Food does not significantly affect absorption; Hydrochlorothiazide: Food may increase absorption slightly.

Distribution:

Vd: Olmesartan: ~17 L; Hydrochlorothiazide: 0.8-1.7 L/kg
ProteinBinding: Olmesartan: >99%; Hydrochlorothiazide: 40-68%
CnssPenetration: Olmesartan: Limited; Hydrochlorothiazide: Limited, crosses placenta and enters breast milk.

Elimination:

HalfLife: Olmesartan: ~13 hours; Hydrochlorothiazide: 5.6-14.8 hours
Clearance: Not available
ExcretionRoute: Olmesartan: Renal (35-50%) and hepatic/biliary (50-65%); Hydrochlorothiazide: Primarily renal (excreted unchanged).
Unchanged: Olmesartan: 35-50% (renal); Hydrochlorothiazide: >95% (renal)
âąī¸

Pharmacodynamics

OnsetOfAction: Olmesartan: Within 1 week for full effect; Hydrochlorothiazide: ~2 hours
PeakEffect: Olmesartan: ~2 weeks; Hydrochlorothiazide: ~4 hours
DurationOfAction: Olmesartan: 24 hours; Hydrochlorothiazide: 6-12 hours

Safety & Warnings

âš ī¸

BLACK BOX WARNING

When pregnancy is detected, discontinue Olmesartan Medoxomil and Hydrochlorothiazide as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of fluid and electrolyte problems, such as:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Fast or abnormal heartbeat
+ Severe dizziness or fainting
+ Increased thirst
+ Seizures
+ Feeling very tired or weak
+ Decreased appetite
+ Changes in urine output
+ Dry mouth
+ Dry eyes
+ Severe stomach upset or vomiting
Signs of pancreatitis (pancreas problems), including:
+ Severe stomach pain
+ Severe back pain
+ Severe stomach upset or vomiting
Chest pain
Swelling in the arms or legs
Persistent diarrhea
Severe diarrhea
Significant weight loss
Dark urine or yellow skin and eyes
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Restlessness

Eye Problems:

This medication can cause certain eye problems, which can lead to permanent vision loss if left untreated. If you experience any eye problems, symptoms such as changes in vision or eye pain usually occur within hours to weeks of starting this medication. Contact your doctor immediately if you experience these symptoms.

Skin Cancer Risk:

Rarely, people taking hydrochlorothiazide have developed certain types of skin cancer. To minimize this risk, protect your skin from the sun and follow your doctor's instructions for skin checks. Contact your doctor immediately if you notice any changes in the color or size of a mole, or any new or changing skin lump or growth.

Other Side Effects:

Most people do not experience serious side effects, but some may occur. If you experience any of the following side effects, contact your doctor or seek medical help if they bother you or do not go away:

Dizziness
Signs of a common cold
* Stomach upset

This is not a comprehensive list of all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting
  • Signs of electrolyte imbalance: unusual tiredness, muscle weakness, muscle cramps, nausea, vomiting, irregular heartbeat, excessive thirst, dry mouth
  • Swelling of the face, lips, tongue, or throat (signs of angioedema)
  • Difficulty breathing or swallowing
  • Persistent, severe diarrhea with significant weight loss
  • Yellowing of the skin or eyes (jaundice)
  • Decreased urination or swelling in the feet/ankles (signs of kidney problems)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
A known sulfa allergy.
Current use of dofetilide.
Inability to urinate.
Use of another medication with similar properties. If you are unsure, consult your doctor or pharmacist for clarification.
Concurrent use of a medication containing aliskiren, particularly if you have diabetes or kidney problems.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine the safety of taking this medication with your existing regimen. Never start, stop, or adjust the dosage of any medication without first consulting your doctor to ensure your safety.
âš ī¸

Precautions & Cautions

Important Warnings and Precautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position, and be cautious when climbing stairs.

Managing High Blood Sugar (Diabetes)
If you have diabetes, closely monitor your blood sugar levels. Be aware of signs of high blood sugar, such as confusion, drowsiness, unusual thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath. Report these symptoms to your doctor.

Monitoring Your Condition
Regularly check your blood pressure as directed by your doctor. Also, have your blood work and other laboratory tests done as scheduled. Note that this medication may affect certain lab tests, so inform all your healthcare providers and lab personnel that you are taking this drug.

Interactions with Other Substances
If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult your doctor. Additionally, discuss your low-salt or salt-free diet with your doctor. Before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or certain natural products, consult your doctor.

Using Other Medications and Substances Safely
Before consuming alcohol, marijuana, or other forms of cannabis, or taking prescription or OTC medications that may slow your reactions, discuss the risks with your doctor.

Taking Other Medications
If you take colesevelam, take it at least 4 hours after taking this medication. If you take cholestyramine or colestipol, consult your pharmacist about the best way to take these medications with this drug.

Staying Safe in Hot Weather
Be cautious in hot weather or during physical activity, and drink plenty of fluids to avoid dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, which can lead to low blood pressure, inform your doctor.

Sun Protection
This medication may increase your risk of sunburn. Take precautions when spending time in the sun, and report any increased sensitivity to your doctor.

Watching for Gout Attacks
Be aware of the signs of gout attacks, and seek medical attention if you experience any symptoms.

Lupus Considerations
If you have lupus, this medication can cause your condition to become active or worsen. Immediately report any new or worsening symptoms to your doctor.

Breastfeeding
If you are breastfeeding, discuss the potential risks to your baby with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Profound hypotension (low blood pressure)
  • Tachycardia (rapid heart rate)
  • Bradycardia (slow heart rate)
  • Electrolyte disturbances (e.g., hypokalemia, hyponatremia)
  • Dehydration
  • Dizziness
  • Weakness

What to Do:

Immediately seek emergency medical attention or call Poison Control at 1-800-222-1222. Treatment is symptomatic and supportive. If ingestion is recent, gastric lavage may be considered. Administer intravenous fluids to support blood pressure. Monitor vital signs and serum electrolytes closely.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment [CrCl < 60 mL/min])
🔴

Major Interactions

  • Lithium (increased serum lithium levels and toxicity)
  • Non-steroidal anti-inflammatory drugs (NSAIDs) including COX-2 inhibitors (reduced antihypertensive effect, increased risk of renal impairment)
  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride) and potassium supplements (increased risk of hyperkalemia)
  • Other antihypertensive agents (additive hypotensive effect)
🟡

Moderate Interactions

  • Corticosteroids, ACTH (intensified electrolyte depletion, particularly hypokalemia)
  • Antidiabetic drugs (oral agents and insulin) (may require dose adjustment of antidiabetic drug due to HCTZ-induced hyperglycemia)
  • Cholestyramine and colestipol resins (impaired absorption of hydrochlorothiazide)
  • Alcohol, barbiturates, or narcotics (potentiate orthostatic hypotension)
  • Digitalis glycosides (hypokalemia/hypomagnesemia may predispose to digitalis toxicity)
  • Muscle relaxants, non-depolarizing (e.g., tubocurarine) (potentiated effect of muscle relaxant)
  • Pressor amines (e.g., norepinephrine) (possible decreased response to pressor amines)
  • Allopurinol (increased risk of hypersensitivity reactions with HCTZ)
  • Calcium salts (increased serum calcium levels due to decreased excretion by HCTZ)
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide therapy.

Timing: Prior to initiation

Serum Electrolytes (Potassium, Sodium, Magnesium, Calcium)

Rationale: To assess baseline electrolyte status, as both components can affect levels.

Timing: Prior to initiation

Renal Function (BUN, Serum Creatinine, eGFR)

Rationale: To assess baseline kidney function, crucial for dosing and to monitor for potential impairment.

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: To assess baseline liver function, especially with HCTZ in hepatic impairment.

Timing: Prior to initiation

Serum Uric Acid

Rationale: HCTZ can increase uric acid levels.

Timing: Prior to initiation

Blood Glucose

Rationale: HCTZ can affect glucose metabolism.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, e.g., weekly initially, then monthly or as clinically indicated

Target: <130/80 mmHg (or individualized target)

Action Threshold: Persistently elevated BP despite therapy; symptomatic hypotension

Serum Electrolytes (Potassium, Sodium)

Frequency: Within 1-2 weeks of initiation/dose change, then every 3-6 months or as clinically indicated

Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L

Action Threshold: Hypokalemia (<3.5 mEq/L), Hyperkalemia (>5.0 mEq/L), Hyponatremia (<135 mEq/L)

Renal Function (BUN, Serum Creatinine, eGFR)

Frequency: Within 1-2 weeks of initiation/dose change, then every 3-6 months or as clinically indicated

Target: Stable within normal limits or baseline

Action Threshold: Significant increase in creatinine (>30% from baseline), decrease in eGFR

Serum Uric Acid

Frequency: Periodically, e.g., every 6-12 months or if symptoms of gout develop

Target: Within normal limits

Action Threshold: Symptomatic hyperuricemia or gout flares

Blood Glucose

Frequency: Periodically, e.g., every 6-12 months, more frequently in diabetic patients

Target: Individualized based on diabetic status

Action Threshold: Significant hyperglycemia

đŸ‘ī¸

Symptom Monitoring

  • Dizziness or lightheadedness (especially upon standing)
  • Excessive fatigue or weakness
  • Signs of electrolyte imbalance (e.g., muscle cramps, weakness, irregular heartbeat, excessive thirst, dry mouth)
  • Swelling of face, lips, tongue, or throat (angioedema - rare but serious)
  • Persistent, severe diarrhea with substantial weight loss (sprue-like enteropathy - rare)
  • Unusual bruising or bleeding (rare, due to thrombocytopenia)
  • Yellowing of skin or eyes (jaundice)

Special Patient Groups

🤰

Pregnancy

Contraindicated during pregnancy. Use of drugs acting on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Discontinue as soon as pregnancy is detected.

Trimester-Specific Risks:

First Trimester: Limited data, but generally advised to avoid ARBs. HCTZ is Category B in 1st trimester.
Second Trimester: High risk of fetal injury and death (renal dysfunction, oligohydramnios, skull hypoplasia, lung hypoplasia, skeletal deformations).
Third Trimester: High risk of fetal injury and death (renal dysfunction, oligohydramnios, skull hypoplasia, lung hypoplasia, skeletal deformations).
🤱

Lactation

Not recommended. Both olmesartan and hydrochlorothiazide are excreted in breast milk. Due to the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: L3 (Moderate risk) - Potential for hypotension, hyperkalemia (from olmesartan), and electrolyte disturbances, jaundice, or thrombocytopenia (from HCTZ) in the infant.
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.

👴

Geriatric Use

No overall differences in efficacy or safety were observed between elderly patients and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Use with caution, especially regarding renal function, as elderly patients are more likely to have impaired renal function.

Clinical Information

💎

Clinical Pearls

  • This combination is not indicated for initial therapy of hypertension. It should be used after a patient has been titrated on the individual components or if blood pressure is not adequately controlled on monotherapy.
  • Monitor serum electrolytes (especially potassium, sodium) and renal function closely, particularly during initiation and dose adjustments, and in patients with pre-existing renal impairment or those on concomitant medications that affect electrolytes.
  • Rarely, olmesartan has been associated with severe, chronic diarrhea with substantial weight loss, sometimes months to years after initiation, consistent with sprue-like enteropathy. If this occurs, discontinue the drug and consider alternative antihypertensive therapy.
  • Hydrochlorothiazide can increase serum uric acid levels and may precipitate gout attacks in susceptible individuals.
  • Patients should be advised to report any signs of angioedema (swelling of face, lips, tongue, or throat) immediately, as this is a serious but rare side effect.
🔄

Alternative Therapies

  • Other classes of antihypertensives (e.g., ACE inhibitors, calcium channel blockers, beta-blockers, other diuretics)
  • Monotherapy with an ARB or a thiazide diuretic, if blood pressure is adequately controlled.
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 for generic per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (generic), Tier 3 or 4 (brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it is a good idea to check with your pharmacist for more information. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.